`
` 1
`
`IN THE UNITED STATES DISTRICT COURT
`MIDDLE DISTRICT OF NORTH CAROLINA
`
`
`OPTOLUM, INC., )
`
` Greensboro, North Carolina )
` Plaintiff, November 8, 2021
` )
` vs. )
`
`)
`CREE, INC., )
`
` Case No. 1:17CV687 )
` Defendant. )
`_________________________________ )
`
`
`
`)
`
`TRANSCRIPT OF TRIAL DAY 8
`BEFORE THE HONORABLE WILLIAM L. OSTEEN, JR.
`UNITED STATES DISTRICT JUDGE
`
`
`APPEARANCES:
`
`For the Plaintiff: ROBERT BROOKS
`LEAH R. MCCOY
`KEITH TOMS
`MCCARTER & ENGLISH, LLP
`265 FRANKLIN STREET
`BOSTON, MA 02110
`
`
`
`JACOB S. WHARTON
`WOMBLE BOND DISKINSON (US) LLP
`1 W. 4th STREET
`WINSTON-SALEM, NC 27101
`
`
`For the Defendant: BLANEY HARPER
`JONES DAY
`51 LOUISIANA AVE., N.W.
`WASHINGTON, DC 20001
`
`
`
`PETER D. SIDDOWAY
`SAGE PATENT GROUP
`4242 SIX FORKS ROAD, SUITE 1550
`RALEIGH, NC 27609
`
`
`Joseph B. Armstrong, FCRR
`Court Reporter:
` 324 W. Market, Room 101
`Greensboro, NC 27401
`
`
`
`Proceedings reported by stenotype reporter.
`Transcript produced by Computer-Aided Transcription.
`
`November 8, 2021 - Trial Day 8
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 2 of 241
`
` 1
`
` 2
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`
`WITNESSES FOR THE DEFENDANT:
`
`I N D E X
`
` 2
`
` PAGE
`
`ROBERT YERMAN
`Direct Examination By Mr. Harper
`Cross-Examination By Mr. Wharton
`
`
`DEFENSE RESTS
`
`WITNESSES FOR THE PLAINTIFF:
`
`12
`78
`
`95
`
`BRENT YORK
`Direct Examination By Mr. Toms
`Cross-Examination By Mr. Harper
`Redirect Examination By Mr. Toms
`
`
`PLAINTIFF RESTS
`
`
`100
`162
`179
`
`181
`
`EXHIBITS: RCVD
`
`PTX 0075
`
`99
`
`99
`
`11
`100
`
`100
`100
`100
`100
`
`100
`99
`
`11
`
`181
`
`11
`
`11
`
`11
`
`November 8, 2021 - Trial Day 8
`
`PTX 0287
`
`DX 288
`DX 0322
`
`PTX 0843
`PTX 0846
`PTX 0849
`PTX 0986
`
`PTX 1219
`
`DX 1220
`
`DX 1223
`
`DX 1225
`
`4/17/2012 Email thread from M. Fallon re:
`THD discussion
`9/14/2011 Email thread from G. Negley re:
`A-Lamp Plan
`CREEAZ_00401883-896
`Monochromatic Hex Specification (2001-107),
`Norlux Corp, 2002 (Bretschneider Invalidity
`Exhibit A-9)
`Decision Denying Institution, IPR2017-01261
`Decision Denying Institution, IPR2017-01260
`Decision Denying Institution, IPR2017-01511
`OPTOLUM-AZ00002674 (Baker Deposition Exhibit
`115)
`The Milani Declaration, Exhibit CC
`PTX 1155
`Cree Xlamp LED Thermal Management
`PTX 1158
`PTX 1204 {TR:6}{P}
`DX 1215
`Summary of Cree’s Filament Tower Costs v.
`Total Material Costs
`Written Description of 5 percent calculation
`(Yerman)
`Summary Chart of Reasonable Royalties March
`2013-2019 (Yerman Expert Report Exhibit 1)
`Revenue and Costs of Various Cree Products
`FY 17 (Yerman Expert Report Exhibit 14)
`Historical Financial Performance Bulbs with
`Filament Tower (Yerman Expert Report Exhibit
`6)
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 3 of 241
`
` 1
`
`I N D E X
`
` 2
`
`EXHIBITS: RCVD
`
` 3
`
`DX 1344
`DX 1345
`
`CREEAZ_00379203-379266
`Https:www.cree.com/news-media/news-article/c
`ree-announces-patent-license-agreement-with-
`ledvance
`
`11
`11
`
`
`
` 3
`
` 4
`
` 5
`
` 6
`
` 7
`
` 8
`
` 9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 4 of 241
`
` 4
`
` 1
`
` 2
`
` 3
`
` 4
`
`P R O C E E D I N G S
`
`November 8, 2021
`
`(At 9:16 a.m., proceedings commenced.)
`
`THE COURT: Good morning, everyone. Anything we need
`
` 5
`
`to take up this morning?
`
` 6
`
`MR. WHARTON: Your Honor, there were several slides
`
` 7
`
`that we still objected to. I previewed that on Friday. I'm
`
` 8
`
`happy to discuss that in greater detail.
`
` 9
`
`THE COURT: All right. Let's put them up on the
`
`10
`
`screen.
`
`11
`
`MR. WHARTON: I can hand up a hard copy as well, Your
`
`12
`
`Honor.
`
`13
`
`THE COURT: Just pull them up on the screen. We'll
`
`14
`
`all be looking at the same thing.
`
`15
`
`16
`
`17
`
`MR. WHARTON: Okay. They're coming.
`
`Okay. Thank you, Mr. Gibson.
`
`The first slide is actually slides 5 and -- no, if we
`
`18
`
`could go to slide 5. So there's no infringement. Damages,
`
`19
`
`zero.
`
`20
`
`Then the next slide, 5-6, no infringement -- or
`
`21
`
`patents not valid. Damages, zero.
`
`22
`
`We object to these as misleading and prejudicial.
`
`23
`
`The damages expert is supposed to assume both validity and
`
`24
`
`infringement. So this is a backdoor way of allowing Mr. Yerman
`
`25
`
`to testify about either validity and/or infringement, neither
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 5 of 241
`
` 5
`
` 1
`
`of which he's an expert on.
`
` 2
`
` 3
`
`THE COURT: Mr. Harper?
`
`MR. HARPER: Your Honor, this slide just goes to his
`
` 4
`
`methodology. The reason that he assumes patents are valid and
`
` 5
`
`infringed is because, otherwise, the damages would be zero in
`
` 6
`
`either case. He's just explaining the methodology, and I think
`
` 7
`
`that that's perfectly appropriate.
`
` 8
`
` 9
`
`THE COURT: All right. Let me see the next one.
`
`MR. WHARTON: The next slide that we object to is
`
`10
`
`slide 14. And here, Mr. Yerman appears to be testifying as to
`
`11
`
`what the patents do not claim. And the slide itself is
`
`12
`
`problematic because he's not an expert on the patents, the
`
`13
`
`scope of the claims, the claim language.
`
`14
`
`If it's fit into the context of commercial success,
`
`15
`
`apportionment, that would be one thing, but the --
`
`16
`
`THE COURT: Doesn't that come directly from
`
`17
`
`Bretschneider's testimony?
`
`18
`
`MR. WHARTON: He testified -- yes, in part. The part
`
`19
`
`that we object to, Your Honor, is the title at the top, that
`
`20
`
`the patents do not claim.
`
`21
`
`If Mr. Yerman testifies that he was here and present
`
`22
`
`for Dr. Bretschneider's testimony, and he heard him discuss
`
`23
`
`that, in Mr. Bretschneider's opinion, that the patents do not
`
`24
`
`enable these characteristics, that's one thing. But for
`
`25
`
`Mr. Yerman to take the stand and say, I, as an expert, do not
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 6 of 241
`
` 6
`
` 1
`
`believe the patents claim X, Y, and Z puts him into the
`
` 2
`
`position of Dr. Bretschneider.
`
` 3
`
` 4
`
`THE COURT: All right. Mr. Harper?
`
`MR. HARPER: Your Honor has already indicated the
`
` 5
`
`factual situation. He's been told that by Dr. Bretschneider.
`
` 6
`
`In fact, there's no dispute about, you know, what's not in the
`
` 7
`
`claim. Omnidirectional light's not in the claim. Effective
`
` 8
`
`thermal management's not in the claim. Form factor is not in
`
` 9
`
`the claim. Those are objective indicia that come from
`
`10
`
`everybody.
`
`11
`
`It's not the question of whether they're in the claim
`
`12
`
`or not. The question is, you know, what does he assume? And
`
`13
`
`the answer is that he has assumed what the technical expert has
`
`14
`
`told him. He's entitled to do that.
`
`15
`
`16
`
`17
`
`THE COURT: All right. Next slide.
`
`MR. WHARTON: That's all we have, Your Honor.
`
`THE COURT: All right. So with respect to each of
`
`18
`
`these, I'll start with slide 5, patents not valid, damages are
`
`19
`
`zero. I think there's multiple things wrapped up in that,
`
`20
`
`including a legal opinion as to what result ensues, depending
`
`21
`
`on the jury's finding. I don't think Mr. Yerman is qualified
`
`22
`
`to give that, so I'm going to sustain that objection.
`
`23
`
`In terms of the patents do not claim, to the extent
`
`24
`
`Mr. Yerman is relying on the testimony of Mr. Bretschneider, he
`
`25
`
`heard that testimony, and he makes it clear in his testimony
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 7 of 241
`
` 7
`
` 1
`
`that he was here and is relying on Bretschneider's testimony to
`
` 2
`
`the following facts. I'll overrule that objection and allow
`
` 3
`
`that slide to be presented.
`
` 4
`
`But there has to be a sufficient foundation laid such
`
` 5
`
`that it's clear to the jury that that's not Mr. Yerman's
`
` 6
`
`opinion, that he's relying on Mr. Bretschneider's testimony to
`
` 7
`
`testify to these things as part of his opinion.
`
` 8
`
` 9
`
`Anything else we need to address?
`
`MR. WHARTON: Your Honor, just for clarity, I believe
`
`10
`
`you sustained the objection as to 5.
`
`11
`
`Does that also apply to 6, the slide that indicates
`
`12
`
`patents not valid --
`
`13
`
`14
`
`15
`
`THE COURT: No, both of them were --
`
`MR. WHARTON: Thank you.
`
`THE COURT: -- no infringement, damages are zero; and
`
`16
`
`validity, damages are zero. I think there's a combination --
`
`17
`
`that there are a number of things going on within that
`
`18
`
`statement, so I'll sustain that.
`
`19
`
`20
`
`Anything else, Mr. Harper?
`
`MR. HARPER: Yeah. I think, since we're at it, to
`
`21
`
`try to limit the interruptions today, there were -- I intend to
`
`22
`
`move into evidence a series of exhibits, three of which have
`
`23
`
`been objected to as being under 401 and 402 being relevance.
`
`24
`
`They are documents that Mr. Yerman prepared. They
`
`25
`
`relate to his opinion, and they're -- actually just express the
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 8 of 241
`
` 8
`
` 1
`
`mathematics behind his opinion. They're documents that he
`
` 2
`
`prepared, and they're relevant to the case.
`
` 3
`
`THE COURT: Can you put them up on the screen so I
`
` 4
`
`can see them?
`
` 5
`
` 6
`
`MR. HARPER: Sure, if we could have 1220, please.
`
`MR. WHARTON: Your Honor, we withdraw our objection
`
` 7
`
`as to 1220.
`
` 8
`
` 9
`
`MR. HARPER: Okay. What about 1223?
`
`MR. WHARTON: Yeah. Your Honor, the concern we have
`
`10
`
`with this is we're trying to determine where -- this is a
`
`11
`
`slide, based on our understanding, that attempts to separate
`
`12
`
`out the double-ring bulbs from the single-ring bulbs. And,
`
`13
`
`where Mr. Yerman is drawing the line, that is, what is he
`
`14
`
`including in the double-ring bulb counting, is where we're
`
`15
`
`having problems with this.
`
`16
`
`THE COURT: What's the 20 LEDs? That's the
`
`17
`
`double-ring bulb?
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`MS. McCOY: That's double ring.
`
`MR. WHARTON: Correct.
`
`THE COURT: All right. And the other one?
`
`MR. HARPER: If we could put up 1215 -- DX 1215.
`
`THE COURT: Objection to this one?
`
`MR. WHARTON: No, Your Honor. We'll withdraw our
`
`24
`
`objection to DX 1215.
`
`25
`
`THE COURT: So 1223 is the only one remaining.
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 9 of 241
`
` 9
`
` 1
`
`Certainly, single ring versus double ring. I mean, the single
`
` 2
`
`rings, we've got some issues, so breaking out the calculations
`
` 3
`
`between the two, I think, is appropriate. I think his
`
` 4
`
`methodology in breaking those out, I confess, I certainly
`
` 5
`
`haven't read his report closely enough to pass judgment on
`
` 6
`
`that, but the numbers have been presented, and I think that's
`
` 7
`
`appropriate for cross-examination.
`
` 8
`
`So, as long as a foundation is laid that would allow
`
` 9
`
`him to make that calculation reflected in 1223, I'll overrule
`
`10
`
`the objection at this point.
`
`11
`
`12
`
`MR. HARPER: Thank you, Your Honor.
`
`THE COURT: At this point, for purposes of pretrial,
`
`13
`
`I'm going to overrule the objection, but that -- you can bring
`
`14
`
`it up again depending on the foundation that's laid before it
`
`15
`
`comes in.
`
`16
`
`17
`
`All right. Anything else this morning?
`
`MR. HARPER: No. There's one housekeeping item in
`
`18
`
`terms of admitting an exhibit that was published to the jury
`
`19
`
`for Mr. Safarikas that, apparently, wasn't moved in, and I'd
`
`20
`
`just like to clean that up this morning as well.
`
`21
`
`22
`
`23
`
`THE COURT: Okay. Do you know the number?
`
`MR. HARPER: Yes, I do. DX 288.
`
`THE COURT: All right. Do y'all know what that is?
`
`24
`
`I have no idea.
`
`25
`
`MS. McCOY: Sorry.
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 10 of 241
`
` 10
`
` 1
`
` 2
`
`MR. WHARTON: I do not know what that is.
`
`THE COURT: I don't recall there being any objections
`
` 3
`
`sustained if it was published to the jury. Let's see if
`
` 4
`
`Ms. Welch can find it for us real quick.
`
` 5
`
` 6
`
`MR. HARPER: It's on the screen, Your Honor.
`
`THE COURT: LED bulbs, the publication relating to
`
` 7
`
`the LED bulbs?
`
` 8
`
` 9
`
`MR. WHARTON: No objection to this coming in.
`
`THE COURT: Move it in front of the jury. I don't
`
`10
`
`know whether they're keeping up with exhibit numbers or not --
`
`11
`
`12
`
`MR. WHARTON: That's fine.
`
`THE COURT: -- but I like for them to know what's
`
`13
`
`admitted and what's not.
`
`14
`
`MR. WHARTON: And we have some housekeeping stuff,
`
`15
`
`but we'll attend to that. I think it's appropriate to do at
`
`16
`
`the beginning of the rebuttal case.
`
`17
`
`THE COURT: Okay. All right. We'll be in recess for
`
`18
`
`five minutes, and we'll come back and bring the jury in.
`
`19
`
`20
`
`21
`
`22
`
`(At 9:26 a.m., break taken.)
`
`(At 9:35 a.m., break concluded.)
`
`(At 9:36 a.m., jurors arrive.)
`
`THE COURT: All right. Mr. Harper, you may call your
`
`23
`
`next witness.
`
`24
`
`MR. HARPER: Thank you, Your Honor. Defendant Cree
`
`25
`
`calls Robert Yerman.
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 11 of 241
`
` 11
`
` 1
`
` 2
`
`(Witness sworn by the clerk.)
`
`THE COURT: Good morning, ladies and gentlemen.
`
` 3
`
`Forgot to greet you when you came in this morning. Welcome
`
` 4
`
`back.
`
` 5
`
` 6
`
` 7
`
`MR. HARPER: May I approach, Your Honor?
`
`THE COURT: You may.
`
`MR. HARPER: Your Honor, before we get started, I'd
`
` 8
`
`like to move in a few exhibits that will be used here.
`
` 9
`
`10
`
`THE COURT: All right.
`
`MR. HARPER: The first one is DX 288, DX 1225,
`
`11
`
`DX 1344, DX 1345, DX 1215, DX 1220, and DX 1223.
`
`12
`
`13
`
`14
`
`15
`
`THE COURT: No other objections?
`
`MR. WHARTON: No objection, Your Honor.
`
`THE COURT: All right. Those exhibits are admitted.
`
`You had an exhibit from earlier in the week you
`
`16
`
`wanted --
`
`17
`
`MR. HARPER: That was the first one I moved in,
`
`18
`
`DX 288. Thank you.
`
`19
`
`THE COURT: Okay. Those exhibits -- 288, 1225, 1344,
`
`20
`
`1345, 1215, 1220, and 1223 are admitted.
`
`21
`
`22
`
`I'm sorry. You may proceed.
`
`MR. HARPER: Just want to make sure I was not
`
`23
`
`stepping on anything.
`
`24
`
`25
`
`THE COURT: Sorry about that.
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 12 of 241
`
`Yerman - Direct
`
` 12
`
` 1
`
` 2
`
` 3
`
` 4
`
`ROBERT YERMAN,
`
`DEFENDANT'S WITNESS, SWORN AT 9:40 a.m.
`
`DIRECT EXAMINATION
`
`BY MR. HARPER:
`
` 5
`
`Q
`
`Good morning. Mr. Yerman, would you please introduce
`
` 6
`
`yourself to the jury.
`
` 7
`
` 8
`
` 9
`
`A
`
`Q
`
`A
`
`Yes, sir. Good morning. I am Robert Yerman.
`
`And where do you live?
`
`I live in a town called Bethesda, Maryland, just outside
`
`10
`
`of Washington, D.C.
`
`11
`
`12
`
`13
`
`14
`
`Q
`
`A
`
`Q
`
`A
`
`What is your current position?
`
`I am a managing director at a company called AlixPartners.
`
`And what is AlixPartners?
`
`AlixPartners is a consulting firm, an accounting
`
`15
`
`consulting firm with over 2,000 employees, and is a firm that
`
`16
`
`works in a few different areas.
`
`17
`
`I am involved in what is called financial advisory
`
`18
`
`services. In addition to that division, the firm has
`
`19
`
`enterprise improvement, which is consulting like you see
`
`20
`
`McKinsey doing, Bain & Company. Those are some of the
`
`21
`
`companies that we compete with for our enterprise improvement.
`
`22
`
`We also do -- maybe the largest firm in the world in
`
`23
`
`what's called troubled debt restructuring. When a company gets
`
`24
`
`in trouble, and before they file, or if they consider filing
`
`25
`
`for bankruptcy, we work with them, help them set up their
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 13 of 241
`
`Yerman - Direct
`
` 13
`
` 1
`
`systems, their actions, their plan, so they can reorganize if
`
` 2
`
`they don't go into bankruptcy.
`
` 3
`
`We also have a division that does digital work, helps
`
` 4
`
`companies. In today's era, digital is the most important thing
`
` 5
`
`that companies are facing, the challenges with digital and how
`
` 6
`
`to use it to their advantage.
`
` 7
`
`We also do -- in the financial advisory services
`
` 8
`
`group, which I am in, we do litigation. We work for
`
` 9
`
`plaintiffs, we work for defendants, we work in patent cases.
`
`10
`
`We work in all sorts of disputes between parties.
`
`11
`
`Q
`
`Does your job at AlixPartners have anything to do with
`
`12
`
`intellectual property valuation?
`
`13
`
`A
`
`Yes, sir. As part of the financial advisory services, we
`
`14
`
`do business valuations, we do license evaluations, we do
`
`15
`
`technology evaluations. We're called upon by different
`
`16
`
`companies to value their patents, their trademarks, copyrights.
`
`17
`
`These are all part of the valuations that we do, value the
`
`18
`
`companies themselves.
`
`19
`
`20
`
`Q
`
`A
`
`And your work, in particular, how does it relate to this?
`
`That's what I have done over my 30-some-odd years doing
`
`21
`
`this type of work. I have been involved in all of those areas
`
`22
`
`at one point or another.
`
`23
`
`24
`
`Q
`
`A
`
`Mr. Yerman, what have you been asked to do in this matter?
`
`I have been asked to assume -- in fact, every expert must
`
`25
`
`assume -- that the patents are not invalid, they are valid, and
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 14 of 241
`
`Yerman - Direct
`
` 14
`
` 1
`
`that the Defendant, Cree, in this case, has infringed them.
`
` 2
`
`Based on those two assumptions, I have been asked to
`
` 3
`
`determine what the damages -- what is OptoLum entitled to?
`
` 4
`
`What were the value of the patents, the technology in the
`
` 5
`
`patents to OptoLum? And I've also been asked to comment on
`
` 6
`
`Mr. Scally, some of his assumptions and his conclusions.
`
` 7
`
` 8
`
`Q
`
`A
`
`Please describe your background.
`
`I was -- my first real position in accounting -- first, I
`
` 9
`
`am a certified public accountant. I was also what's called a
`
`10
`
`certified fraud examiner, which is really what you do in
`
`11
`
`investigations.
`
`12
`
`I was a partner in a firm called Touche Ross. Many
`
`13
`
`years ago, when I first started in public accounting, there
`
`14
`
`were eight large firms, and they were called the Big 8. Touche
`
`15
`
`Ross was one of the big accounting firms. I was a partner in
`
`16
`
`charge at Touche Ross. I was an audit partner, so in that
`
`17
`
`role, what I did was I ran the audits. I also ran some of our
`
`18
`
`consulting that we did. So that was the first -- my first real
`
`19
`
`auditing, accounting, consulting work.
`
`20
`
`I was with Touche Ross for about 20 years. In 1989
`
`21
`
`or '90, I believe, Touche Ross merged with another of the Big 8
`
`22
`
`firms, a firm called Deloitte. So the combination became
`
`23
`
`Deloitte & Touche. I stayed with that firm for one year, and
`
`24
`
`then I had an opportunity. I was approached by another firm,
`
`25
`
`which I thought would be more interesting to me, and I really
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 15 of 241
`
`Yerman - Direct
`
` 15
`
` 1
`
`changed what I was doing.
`
` 2
`
`I was approached by a firm called Coopers & Lybrand,
`
` 3
`
`which was another of the Big 8 firms. And what I did was I
`
` 4
`
`joined Coopers & Lybrand, but instead of doing auditing -- I
`
` 5
`
`was an audit partner -- a senior audit partner at Touche. What
`
` 6
`
`I did at Coopers was financial advisory services.
`
` 7
`
`So I did consulting within the industries. I helped
`
` 8
`
`companies value their businesses, their assets. I was involved
`
` 9
`
`as an expert in litigation. I started to do patent, trademark,
`
`10
`
`copyright, trade secret cases. I did breach of contract. I
`
`11
`
`became what's called an expert witness at Coopers & Lybrand.
`
`12
`
`In fact, I ran Coopers & Lybrand's intellectual property
`
`13
`
`practice for the Greater Washington area. So it's the East
`
`14
`
`Coast, mid-Atlantic area.
`
`15
`
`I stayed with Coopers until it merged with
`
`16
`
`Pricewaterhouse. I had lived through one merger, and, for me,
`
`17
`
`that's not what I like to do. Mergers create all sorts of
`
`18
`
`issues, some good, some bad. I just felt that this was not
`
`19
`
`what I wanted to do.
`
`20
`
`And, at that time, while the firm had announced their
`
`21
`
`merger, I was approached by a company called Law & Economics
`
`22
`
`Consulting Group, LECG. This is a firm that was made up of
`
`23
`
`some of the foremost economists in the world, and they asked me
`
`24
`
`to join them. I joined them.
`
`25
`
`I became their national director of the intellectual
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 16 of 241
`
`Yerman - Direct
`
` 16
`
` 1
`
`property practice, so I ran -- intellectual property is
`
` 2
`
`referred to as IP, the intellectual property. I ran the
`
` 3
`
`intellectual property practice for -- Law & Economics
`
` 4
`
`Consulting changed their name to LECG, so I ran the IP
`
` 5
`
`practice.
`
` 6
`
`I also was the partner in charge, we called it
`
` 7
`
`managing director. I was the in-charge person for the
`
` 8
`
`Washington office, which was the largest office in the firm,
`
` 9
`
`and I stayed with LECG until the company literally went out of
`
`10
`
`business about 10 years ago. Just internal problems. We were
`
`11
`
`a public company. We were bought -- control was bought by an
`
`12
`
`investor. There were problems with the way it was run. The
`
`13
`
`company went out of business.
`
`14
`
`Fortunately, before we really went out of business,
`
`15
`
`AlixPartners, some of the people, the leaders of the financial
`
`16
`
`advisory practice of AlixPartners, had approached me and asked
`
`17
`
`me if I would be willing to leave LECG and join AlixPartners,
`
`18
`
`do essentially the same thing.
`
`19
`
`So I joined AlixPartners, I believe, in 2011, about
`
`20
`
`10 years ago. So I have been with AlixPartners as a managing
`
`21
`
`director and doing, essentially, expert witness, mostly
`
`22
`
`patents, trademarks, copyrights, trade secrets. I also did
`
`23
`
`some investigations. I've also done consulting. I've done
`
`24
`
`valuation. I've been asked to value intellectual property.
`
`25
`
`I've performed valuations of companies, and that's where
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 17 of 241
`
`Yerman - Direct
`
` 17
`
` 1
`
`essentially I am at today.
`
` 2
`
`Q
`
`Explain how your job, your work experience applies or is
`
` 3
`
`relevant to the task that you've been asked to undertake in
`
` 4
`
`this matter.
`
` 5
`
`A
`
`Well, what I do in a non -- let's start with
`
` 6
`
`non-litigation work. I am asked to value -- to help companies
`
` 7
`
`value their assets, their what's called intangible assets.
`
` 8
`
`Maybe let me just jump into that.
`
` 9
`
`Intangible assets are things you cannot touch. A
`
`10
`
`tangible asset is something we all know. It's the furniture,
`
`11
`
`it's your computer, it's your machinery. Those are assets you
`
`12
`
`can touch or feel. Intangible assets are very valuable, can be
`
`13
`
`very valuable. Sometimes they have no value, the range is
`
`14
`
`tremendous, but you can't just -- you can't touch them.
`
`15
`
`So a patent, for example, on technology is an
`
`16
`
`intangible asset. So I have been doing that over my career for
`
`17
`
`not tangible assets. I don't value tangible assets. I'm not
`
`18
`
`qualified to do that. But intangible assets, especially
`
`19
`
`intellectual property, that's what I do, that's what I have
`
`20
`
`been doing. And that's, in a sense, what I've done for today.
`
`21
`
`Q
`
`Now, you've mentioned intellectual property a few times.
`
`22
`
`What is it?
`
`23
`
`A
`
`Yeah. It's really, as I said, something you can't touch,
`
`24
`
`so a patent is intellectual property. A trademark, the name
`
`25
`
`that you see -- Coca-Cola is the most valuable trademark in the
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 18 of 241
`
`Yerman - Direct
`
` 18
`
` 1
`
`world. The name Coca-Cola has the most value. They put
`
` 2
`
`Coca-Cola on a product, that has tremendous value. So it's an
`
` 3
`
`asset that you can't touch, but it may have value, and it may
`
` 4
`
`not.
`
` 5
`
`The difference between a tangible asset and an
`
` 6
`
`intangible asset is an intangible asset -- well, let's start
`
` 7
`
`with -- the tangible asset has value from its own -- from
`
` 8
`
`itself. So a piece of furniture has value just as being a
`
` 9
`
`piece of furniture. A car has value being a car. A computer
`
`10
`
`has value because it's a computer. You look up and see what it
`
`11
`
`sold for, either new or used.
`
`12
`
`Intangible assets, you don't just look at the asset.
`
`13
`
`You have to look at how it's going to be used, how it compares
`
`14
`
`with other items, other intangible assets that are similar to
`
`15
`
`it. That is the major difference between a tangible and an
`
`16
`
`intangible asset.
`
`17
`
`Q
`
`And describe, if you would, the industries for which
`
`18
`
`you've done this intangible asset valuation over the years.
`
`19
`
`A
`
`Oh, well, I've been involved in so many patent cases that
`
`20
`
`the industries range from -- I value fan blades on the A380
`
`21
`
`aircraft. That's the largest aircraft I have ever seen. And
`
`22
`
`Pratt Whitney, who made the engine, was sued by Rolls-Royce.
`
`23
`
`And Rolls-Royce asked the Court, the jury, to pay it damages of
`
`24
`
`$4 billion for what they claimed was the infringement of the
`
`25
`
`fan blades in the engines on the A380 aircraft.
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 19 of 241
`
`Yerman - Direct
`
` 19
`
` 1
`
`Ultimately, I said the damages were much less, much
`
` 2
`
`less, in the -- less than $50 million; a lot of money, but
`
` 3
`
`still a lot different than $4 billion. The Court agreed with
`
` 4
`
`me, and, in fact, the Court did not permit the expert in
`
` 5
`
`trial -- when this was going to trial, the Court did not permit
`
` 6
`
`the expert to testify. He told the expert she could not
`
` 7
`
`testify to $4 billion. She limited the testimony to no greater
`
` 8
`
`than $400 million. She knocked it down by over 90 percent
`
` 9
`
`because of the objections and what we pointed out to the judge,
`
`10
`
`and the judge agreed with that.
`
`11
`
`THE COURT: All right. Mr. Yerman, in terms of what
`
`12
`
`the judge did or didn't do, the question was -- I'm going to
`
`13
`
`strike that.
`
`14
`
`15
`
`16
`
`17
`
`18
`
`The question was, describe the industries --
`
`THE WITNESS: I'm sorry --
`
`THE COURT: -- on each case.
`
`THE WITNESS: Sorry, Your Honor.
`
`Okay. So aircraft is one industry, and I've done a
`
`19
`
`number of cases in the aircraft. I've done what's called the
`
`20
`
`auxiliary power unit on aircraft. I valued that. I've worked
`
`21
`
`in the medical industry. I have valued pharmaceutical
`
`22
`
`products, pills. I've worked in the equipment industry. I
`
`23
`
`valued technology used in data readers where you scan and the
`
`24
`
`numbers that you see on the bar codes.
`
`25
`
`I've worked in the oil and gas industry on fracking,
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 20 of 241
`
`Yerman - Direct
`
` 20
`
` 1
`
`refracking. That's an industry where you go in -- and fracking
`
` 2
`
`means you go back in and dig it up and try and get more oil or
`
` 3
`
`gas out of the ground. Refracking is the secondary -- when oil
`
` 4
`
`prices are so high, you can afford to go in and do it twice and
`
` 5
`
`get the remainder out.
`
` 6
`
`I think -- I mean, I've worked in a dozen other
`
` 7
`
`industries, also.
`
` 8
`
`BY MR. HARPER:
`
` 9
`
`Q
`
`Now, you've indicated that you've worked on a number of
`
`10
`
`intellectual property litigation. Have you testified before?
`
`11
`
`A
`
`Yes, sir. I've testified in various cases, probably 30,
`
`12
`
`40 times.
`
`13
`
`MR. HARPER: Your Honor, at this time, I offer up
`
`14
`
`Mr. Yerman as an expert in the valuation and licensing of
`
`15
`
`intellectual property.
`
`16
`
`17
`
`18
`
`THE COURT: Voir dire?
`
`MR. WHARTON: No objection, Your Honor.
`
`THE COURT: All right. Mr. Yerman may testify as an
`
`19
`
`expert in the field of intellectual property valuation and
`
`20
`
`licensing.
`
`21
`
`22
`
`23
`
`You may proceed.
`
`MR. HARPER: Thank you.
`
`BY MR. HARPER:
`
`24
`
`Q
`
`Mr. Yerman, what is your opinion concerning the proper
`
`25
`
`amount of damages that should be awarded based on the
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 21 of 241
`
`Yerman - Direct
`
` 21
`
` 1
`
`assumption that the '028 patents are valid and infringed?
`
` 2
`
`A
`
`You can see on this slide how I came to my assumption.
`
` 3
`
`I'll just quickly walk through this.
`
` 4
`
`What you do is you start with the net sales. And I
`
` 5
`
`think Mr. Scally talked about the gross sales and returns and
`
` 6
`
`allowances and net sales. Net sales are what companies pay
`
` 7
`
`royalties on if they have a licensing agreement.
`
` 8
`
`So I talked to Jason Young, who's testified in court,
`
` 9
`
`asked him how he compiled the numbers. We talked about what
`
`10
`
`his responsibility was to produce the sales -- gross and net
`
`11
`
`sales for all bulbs that contain or practice what OptoLum
`
`12
`
`alleges is their patented technology. That came out to about
`
`13
`
`312 million. That's the 311,768 that you see up on the screen.
`
`14
`
`The next thing that you must do, and every damage
`
`15
`
`expert has to do this, is we do what's called apportionment.
`
`16
`
`You have to separate the value that the technology provides to
`
`17
`
`the ultimate product. So, for example, a bulb has multiple
`
`18
`
`features. It clearly has -- this bulb had a filament tower,
`
`19
`
`but this bulb also had electronics. It had dimmability. It
`
`20
`
`had all sorts of other features.
`
`21
`
`So I had to -- or all experts have to do what's
`
`22
`
`called an apportionment, is determine how much -- assuming that
`
`23
`
`the patents are valid, and assuming that the patents are
`
`24
`
`infringed, how much value do those -- did that technology bring
`
`25
`
`to the final product?
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 22 of 241
`
`Yerman - Direct
`
` 22
`
` 1
`
`I went and made a determination that 71 percent of
`
` 2
`
`the value of the bulbs is attributable to what OptoLum has
`
` 3
`
`claimed -- or OptoLum's expert has claimed is the value of
`
` 4
`
`their patents, the two patents that they have.
`
` 5
`
`So, therefore, you see the royalty base is the net
`
` 6
`
`sales apportioned appropriately, which everyone has to do. All
`
` 7
`
`experts must do that.
`
` 8
`
`I then had to determine what the appropriate royalty
`
` 9
`
`rate was, and I came up with a rate from an existing license.
`
`10
`
`This is what Cree has been paying -- this is what Cree has
`
`11
`
`received from another company when Cree licensed its
`
`12
`
`technology. OptoLum has not licensed its technology to anyone
`
`13
`
`else as far as I know.
`
`14
`
`So I multiplied the $221 million net sales by the
`
`15
`
`1.1 percent reasonable royalty, and that gives you damages of
`
`16
`
`2,400,000-some-odd. This is under the assumption that all of
`
`17
`
`the bulbs that OptoLum has claimed infringe actually do
`
`18
`
`infringe.
`
`19
`
`Yeah, there's a counterclaim, though, or a
`
`20
`
`counter-assumption that Cree has made, and I have been asked to
`
`21
`
`determine what the damages are -- can I see the next slide,
`
`22
`
`please.
`
`23
`
`Q
`
`If we go to the next slide -- if you could tell us what
`
`24
`
`this next slide is about, please.
`
`25
`
`A
`
`Yes, sir. I've been asked to make the assumption that
`
`November 8, 2021 - Trial Day 8
`
`
`
`Case 1:17-cv-00687-WO-JLW Document 381 Filed 08/09/22 Page 23 of 241
`
`Yerman - Direct
`
` 23
`
` 1
`
`only the bulbs with multiple rings infringe. So it's a
`
` 2
`
`subsection of that $300 million in sales. You've got bulbs
`
` 3
`
`with one ring and you've got bulbs with multiple rings. I have
`
` 4
`
`been asked -- if you, the jury, find that only the bulbs with
`
` 5
`
`multiple rings infringe, how much would damages be?
`
` 6
`
`And the only difference between this slide and the
`
` 7
`
`previous slide is there are only 90 -- only -- there's
`
` 8
`
`$92 million of sales of these bulbs, the bulbs with multiple
`
` 9
`
`rings, as compared to the 312 million of sales of bulbs with
`
`10
`
`multiple and single ring.
`
`11
`
`So if it's only the bulbs -- if you find that it's
`
`12
`
`only the bulbs with multiple rings, the damages are the same --
`
`13
`
`I did the same process. I did an apportionment. I applied the
`
`14
`
`1.1 percent. You come up with $721,000 of damages.
`
`15
`
`Q
`
`We'll come back to this calculation in a moment, but
`
`16
`
`explain what were the materials that you looked at in your
`
`17
`
`evaluation of the reasonable royalty opinion in this case



